CA9 and cancer: To the best of our knowledge, such a model system has not been developed before—most of the studies reporting on non‐clinical studies involving CAIX as a target have used shRNA‐mediated silencing of CAIX in cancer cells [17, 18, 19], including the 4T1 model [16].